Par Drugs And Chemicals Ltd.
NSE: PAR
₹93.88
₹1.00
(1.08%)
As on 07-May-2026IST
Market cap
₹116 Cr
Revenue (TTM)
₹106 Cr
P/E Ratio
8.3
P/B Ratio
1
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹14 Cr
-
ROE
14.5 %
-
ROCE
19.5 %
-
Industry P/E
59.42
-
EV/EBITDA
3.6
-
Debt to Equity
0
-
Book Value
₹90.4
-
EPS
₹11.3
-
Face value
10
-
Shares outstanding
12,304,636
10 Years Aggregate
CFO
₹91.71 Cr
EBITDA
₹134.11 Cr
Net Profit
₹71.09 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Par Drugs
| -7.3 | 9.6 | 2.4 | -6.5 | -17.3 | 8.9 | -- |
|
BSE Healthcare
| 6.8 | 11.7 | 10.6 | 10.4 | 26.1 | 14.0 | 11.7 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
|---|---|---|---|---|---|---|
|
Par Drugs
| -51.1 | -8.4 | 42.8 | -24.9 | 470.1 | 65.5 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Par Drugs
|
93.9 | 115.5 | 106.4 | 13.9 | 13.6 | 13.5 | 8.3 | 1.0 |
| 2,725.7 | 22,282.9 | 1,339.4 | 356.4 | 33.2 | 23.2 | 62.5 | 13.5 | |
| 776.6 | 15,279.8 | 7,266.8 | 627.5 | 11.9 | 12.6 | 24.3 | 2.8 | |
| 484.9 | 18,550.7 | 2,051.5 | 180.5 | 11.6 | 7.7 | 92 | 4.9 | |
| 743.5 | 18,420.0 | 5,365.6 | 595.0 | 16.6 | 13.3 | 31 | 3.6 | |
| 1,155.2 | 20,672.9 | 4,560.2 | 1,544.6 | 35.1 | 19.2 | 13.3 | 2.4 | |
| 1,815.9 | 20,825.4 | 1,419.3 | 20.1 | 8.4 | 0.5 | 1036 | 3.6 | |
| 183.7 | 24,438.2 | 8,869.1 | -383.1 | 1.0 | -4.2 | -- | 3.0 | |
| 467.4 | 18,948.2 | 3,738.7 | 316.7 | 12.5 | 7.5 | 59.8 | 3.9 | |
| 1,637.5 | 26,595.9 | 3,373.0 | 199.0 | 12.6 | 5.9 | 124.9 | 5.4 |
Shareholding Pattern
View DetailsNews & Analysis
All News
About Par Drugs
Par Drugs and Chemicals Limited develops, manufactures, and sells active pharmaceutical ingredients (APIs) and fine chemicals in India. The company provides API products, including magnesium hydroxide, magnesium oxide USP, sucralfate, almagate BP,... dried aluminium hydroxide gel, light magnesium carbonate, magaldrate, magnesium trisilicate, colloidal silicon dioxide, aluminium magnesium silicate, magnesium aluminometasilicate, magnesium aluminosilicate-USP, magnesium oxide light, magnesium oxide heavy, magnesium aluminium hydrate, hydrotalcite, and synthetic aluminium silicate. It offers fine chemicals, such as precipitated silica, sodium aluminium silicate, amorphous aluminium hydroxide, Alusil, PARSIL-HT, aluminium hydroxide magnesium carbonate co-dried gel, magnesium aluminium silicate hydrated (pharma), and magnesium aluminium silicate hydrated (agro). It also exports its products. Par Drugs and Chemicals Limited was founded in 1982 and is based in Vadodara, India. Read more
-
Incorporated
1999
-
Chairman
Falgun Vallabhbhai Savani
-
Managing Director
Falgun Vallabhbhai Savani
-
Headquarters
Vadodara, Gujarat
-
Website
Looking for more details about Par Drugs And Chemicals Ltd.’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Announcements
View AnnouncementsFAQs for Par Drugs
What is the current share price of Par Drugs And Chemicals Ltd Today?
The share price of Par Drugs And Chemicals Ltd is ₹93.88 (NSE) as of 07-May-2026 IST. Par Drugs And Chemicals Ltd has given a return of -17.26% in the last 3 years.
What is the current PB & PE ratio of Par Drugs And Chemicals Ltd?
The P/E ratio of Par Drugs And Chemicals Ltd is 8.31 times as on 07-May-2026, a 86 discount to its peers’ median range of 59.42 times.
The P/B ratio of Par Drugs And Chemicals Ltd is 1.04 times as on 07-May-2026, a 71 discount to its peers’ median range of 3.62 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
7.82
|
1.06
|
|
2024
|
18.28
|
3.10
|
|
2023
|
15.20
|
2.42
|
|
2022
|
21.34
|
3.28
|
|
2021
|
3.28
|
1.46
|
What is the 52 Week High and Low of Par Drugs And Chemicals Ltd?
The 52-week high and low of Par Drugs And Chemicals Ltd are Rs 122.43 and Rs 78.05 as of 08-May-2026.
What is the market cap of Par Drugs And Chemicals Ltd?
Par Drugs And Chemicals Ltd has a market capitalisation of ₹ 116 Cr as on 07-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Par Drugs And Chemicals Ltd?
Before investing in Par Drugs And Chemicals Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.